Ocumension Therapeutics·144

May 26, 7:00 AM ET

EyePoint Pharmaceuticals, Inc. 144

144 · Ocumension Therapeutics · Filed May 26, 2023

Documents

1 file
  • 144
    primary_doc.xmlPrimary